ViiV Healthcare Company v. Gilead Sciences, Inc.
1:18-cv-00224
Overview
Parties
Defendant
Gilead Sciences, Inc. Operating Company
Represented By
17 Attorneys ListedMorris, Nichols, Arsht & Tunnell
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Morris, Nichols, Arsht & Tunnell
1201 North Market St., P.O. Box 1347, Wilmington, DE 19899
Morris, Nichols, Arsht & Tunnell, LLP
1201 North Market St., PO Box 1347, Wilmington, DE 19801
Plaintiff
Shionogi & Co., Ltd. Operating Company
Represented By
19 Attorneys ListedDLA Piper LLP (US)
1201 North Market St., Suite 2100, Wilmington, DE 19801
ViiV Healthcare Company NPE (Individual / Inventor)
Represented By
23 Attorneys ListedDLA Piper LLP (US)
1201 North Market St., Suite 2100, Wilmington, DE 19801
ViiV Healthcare UK (No. 3) Limited NPE (University / Research)
Represented By
20 Attorneys ListedDLA Piper LLP (US)
1201 North Market St., Suite 2100, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 23 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8129385
Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
|
Filed: 2006-04-28
Issued: 2012-03-06
|
Active (0.9 yrs remaining)
+525d PTA
Expires: 2027-10-05
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+525 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
100
Dispositive
16
Granted
1
Denied
7
Pending / Review
66
Motions by Category
Key Dispositive Motions & Rulings